MedTrace Logo

Prevention for the Restenosis of Intracranial Artery Stent Implantation Treated With Herbal Medicine C117

NCT03008798 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 180

Last updated 2017-01-02

No results posted yet for this study

Summary

Prevention for the Restenosis of Intracranial artery Stent Implantation Treated with herbal medicine C117--PRISIT Trial

Conditions

  • Occlusion and Stenosis of Unspecified Cerebral Artery

Interventions

DRUG

Herbal Medicine C-117

C117 formula including 2 herbals and 2 insects

DRUG

The Placebo of Herbal Medicine C-117

Sponsors & Collaborators

  • Liaocheng People's Hospital

    collaborator OTHER

  • Liaoning Cancer Hospital & Institute

    collaborator OTHER

  • Zhongshan People's Hospital, Guangdong, China

    collaborator OTHER

  • Guangzhou University of Traditional Chinese Medicine

    lead OTHER

Principal Investigators

  • Yingguang Zhang, MD · Guangdong Province Hospital of Tradtional Chinese Medicine

  • Zhangyong Xia, MD · Liaocheng People's Hospital

  • Jian Yang, MD · Liaoning Cancer Hospital & Institute

  • Wentong Ling, MD · Zhangshan People's Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-31
Primary Completion
2019-12-31
Completion
2019-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03008798 on ClinicalTrials.gov